Skip to main content
Download PDF

Causal effects of genetically vitamins and sepsis risk: a two-sample Mendelian randomization study

BMC Infectious Diseases volume 23, Article number: 766 (2023) Cite this article

Abstract

Background

In recent years, observational studies have been conducted to investigate the potential impact of vitamins on sepsis. However, many of these studies have produced inconsistent results. Our Mendelian randomization (MR) study aims to evaluate the causality between vitamins and sepsis from a genetic perspective.

Methods

Our MR study was designed following the STROBE-MR guidelines. Genetic instrumental variables for vitamins including folate, vitamin B12, B6, A (Retinol), C, D, and K were obtained from previous genome-wide association studies (GWAS) and MR studies. Five different sepsis severity levels were included in the analysis. The genetic instrumental variables were screened for potential confounders using PhenoScanner V2. MR analysis was performed using MR-egger, inverse-variance weighted multiplicative random effects (IVW-RE), inverse-variance weighted multiplicative fixed-effects (IVW-FE), and wald ratio methods to assess the relationship between vitamins and sepsis. Sensitivity analysis was performed using the MR-egger_intercept method, and the MR-PRESSO package and Cochran’s Q test were used to evaluate the heterogeneity of the instrumental variables.

Results

Our MR study found no statistically significant association between vitamins and sepsis risk, regardless of the type of vitamin (P-value > 0.05). The odds ratios (ORs) for folate, vitamin B6, vitamin B12, vitamin A, vitamin D, vitamin K, and vitamin C were 1.164 (95% CI: 0.895–1.514), 0.987 (95% CI: 0.969–1.005), 0.975 (95% CI: 0.914–1.041), 0.993 (95% CI: 0.797–1.238), 0.861 (95% CI: 0.522–1.42), 0.955 (95% CI: 0.86–1.059), and 1.049 (95% CI: 0.911–1.208), respectively. Similar results were observed in subgroups of different sepsis severity levels.

Conclusions

Our MR study found no evidence of a causal association between vitamins and sepsis risk from a genetic perspective. Further randomized controlled trials are necessary to confirm these results.

Peer Review reports

Introduction

As the most common trigger of infection-related death, sepsis is the result of an unbalanced host immune response to infection [1]. Sepsis is often accompanied by persistent inflammation, organ failure, and vascular endothelial and mitochondrial dysfunction [2]. There were 11 million sepsis-related deaths in the world in 2017, which made up 19.7% of all fatalities [3]. Early broad-spectrum antimicrobial therapy is considered crucial [4] and general critical care also play an important role [5] in treating sepsis.

Vitamins are essential micronutrients in the human body. It has been widely reported that vitamins can prevent infections, reduce inflammation, and increase antioxidant activity [6]. Thus, adjuvant vitamin therapy in critical illness like sepsis is getting more and more attention, especially for vitamin C and vitamin D [7]. Related randomized controlled trials have been conducted, but results have been inconsistent. It is well known that vitamin C (ascorbic acid) has powerful antioxidant properties. However, researchers found vitamin C to be risky for patients with sepsis in a recent study. Within 28 days, patients who with sepsis receiving vasopressor therapy in the ICU are more likely to die or experience organ dysfunction after intravenous vitamin C injection [8]. This result is different from previous studies and needs more verification. Vitamin D also helps the body’s immune system and suppress inflammation. But different studies had yielded heterogeneous results [9]. Apart from vitamin C and D, other vitamins may also have potential association with sepsis and changes in the concentrations of many vitamins can be observed in people with sepsis. According to a study, children with sepsis are more likely to be vitamin A deficient, which may lead to a higher mortality rate [10]. But the effectiveness of vitamins in treating sepsis remains controversial.

Therefore, unlike previous randomized controlled trials, in our study, the causality between vitamins and sepsis is explained genetically. Our study included five different levels of sepsis and a variety of common vitamins, including B vitamins (folate, vitamin B12, vitamin B6), Vitamin A(Retinol), Vitamin C, Vitamin D, Vitamin K. Confounders and reverse causality can be problematic in traditional observational studies. And these studies have high requirements for implementation conditions. In our study, we use mendelian randomization to study the causal effects between vitamins and sepsis. Mendelian randomization is based on Mendelian laws of heredity. Parents’ alleles are randomly assigned to their offspring in natural conditions, a process similar to randomization in randomized controlled trials, but without environmental confounders factors.

Methods

Mendelian randomization study design

This study is designed according to the STROBE-MR guidelines [11] to make sure that we’ve done every step of Mendelian randomization analysis. Our complete study design is shown in Fig. 1. An MR study with two samples is conducted to examine the causality between genetically vitamins and sepsis risk. It is the first study to use Mendelian randomization to analyze the effect of vitamins on sepsis of different severity from a genetic perspective. What’s more we also analyzed the effect of sepsis on plasma vitamin C levels.

Fig. 1
figure 1

The flow chart shows the content and process of our research

Full size image

Mendelian randomization studies need to follow three assumptions. In analyzing the effects of vitamins on different levels of severity, assumption 1 is that instrumental variables (IVs) are strongly associated with exposure, namely different vitamins. Assumption 2 is that IVs can only be related to exposure factors, not confounders factors (such as age, sex, BMI, etc.). Assumption 3 is that SNP can only affect the outcome(sepsis) through vitamins, not through other pathways. The study of the effects of sepsis on plasma vitamin C levels also follows the three assumptions described above.

Data source

In this study, we have selected genetic instrumental variables from previously conducted genome-wide association studies (GWAS) and Mendelian Randomization (MR) analyses, focusing mainly on vitamins that have been researched in the context of infectious diseases. We ensured that the vitamins included are backed by publicly accessible GWAS data, thus facilitating the MR analysis. It is important to note that, due to the inability to represent external vitamin intake or injections through genetic instrumental variables, our approach hinges on using GWAS data derived from the concentrations of vitamins measured in circulating blood. SNPs of B vitamins (folate, vitamin B12, vitamin B6) are selected from a previous mendelian randomization study [12]. The SNPs estimated 1. 0% of heritability for folate, 1. 3% of heritability for vitamin B6 and 6. 0% of heritability for vitamin B12 [12]. SNPs of vitamin A (circulating retinol levels) are selected from a GWAS study, which includes two cohorts of men with 5006 Caucasian individuals [13]. SNPs of vitamin C (plasma vitamin C levels) are selected from a meta-analysis of EPIC-Norfolk, Fenland, EPIC-InterAct, and EPIC-CVD study with a total of 52, 018 individuals [14]. Instrumental variables of vitamin D (25-hydroxyvitamin D serum concentrations) are extracted from a large-scale GWAS meta-analysis with 79, 366 individuals, which explained 7. 5% variance for vitamin D [15]. SNPs of vitamin K (circulating phylloquinone concentrations) are extracted from a Meta-analysis of GWAS studies [16]. Only 2 unrelated SNPs of vitamin K are selected after removing the highly correlated SNPs, SNPs strongly related to lipids and SNPs not in our outcome data.

The GWAS data for sepsis of different severity were derived from a reanalysis of the UK Biobank data in 2021 [17]. Our study included sepsis of varying severity, including Sepsis, Sepsis (critical care), Sepsis (under 75), Sepsis (28-day death), Sepsis (28-day death in critical care). For those traits, the unit is logOR. The sex includes males and females. The population is European. These septic traits were used as outcome of vitamin exposures and as exposure of plasma vitamin C levels outcome.

All study populations and cohorts were European populations. This ensures that the study is carried out in a homogeneous population, satisfying the Hardy-Weinberg law of population inheritance. Detailed information as well as related articles are listed in the Table 1.

Table 1 Data source and detailed information of vitamins and different severity of sepsis
Full size table

Genetic instrumental variable selection

We use TwoSampleMR R package (version 0. 5. 6) to choose suitable SNPs. Instrumental variables require a strong correlation with exposure (p < 5 × 10− 8). When the exposures are vitamins, the above filter condition can be met, while when sepsis is exposure, the above filter condition (p < 5 × 10− 8) cannot be met. Therefore, the weaker filter condition (p < 5 × 10− 6) is used to select the instrumental variables of sepsis. Moreover, these SNPs with the linkage disequilibrium (LD)need to be removed to ensure that they inherit independently (r2 = 0.001, kb = 10,000) from each other. Palindromic SNPs that may cause strand ambiguity are also removed. In addition, in order to satisfy assumption 2, 3, we searched the SNPs already obtained through PhenoScanner V2 (http://www.phenoscanner.medschl.cam.ac.uk/) [18] to find potential confounders and bypassing (e.g. Age, sex, race or ethnicity, underlying disease) [2] that might influence the association between vitamins and sepsis. SNPs associated with confounders are removed. Then we calculate F statistics (F = beta2/se2) [19] for each SNP to evaluate SNP’s statistical power. SNPs with inadequate statistical power (F < 10) were excluded.

Mendelian randomization analysis

The TwoSampleMR R package (version 0. 5. 6) was used to perform the mendelian Randomization(MR) analysis. For exposures with three or more SNPs, we chose three methods including MR-egger, inverse-variance weighted multiplicative random effects (IVW-RE) and inverse-variance weighted multiplicative fixed-effects (IVW-FE) to evaluate the association between vitamins and sepsis. For exposures with two SNPs, only the latter two methods are applicable. For exposures with one SNP, we adopted the Wald ratio method to conduct MR. MR analysis yielded a P-value to assess whether there was an association between vitamins and sepsis and an odds ratio(OR) to assess the extent to which exposure affected the outcome. The P-value should be less than 0. 05 to indicate a significant association. For the selection of the above MR Methods, we need to conduct sensitivity and heterogeneity analysis for the acquired SNPs. Sensitivity analysis was conducted using MR-egger_intercept method when the number of SNPs of exposure was greater than three [20], and P-value < 0. 05 is considered pleiotropic. The leave-one-out plots is also used to observe differences in the effect of SNPs. SNPs with great different effects were excluded. For heterogeneity analysis, the MR-PRESSO package [20] was used to identify SNPs with heterogeneity and those SNPs was removed. Cochran’s Q test was also used to assess the heterogeneity of SNPs [21]. Cochran’s Q test includes MR-egger method and inverse variance weighted method. Significant heterogeneity was defined as a P-value less than 0. 05. If the heterogeneity is significant, IVW-RE method is adopted to adjust the heterogeneity; otherwise, IVW-FE method is adopted.

Results

When the exposures are vitamins and outcome was sepsis, we extract one SNP for vitamin B6, two SNPs for folate, thirteen SNPs for vitamin B12, two SNPs for vitamin A, ten SNPs for vitamin C, five SNPs for vitamin D, two SNPs for vitamin K. We have removed the SNPs that does not satisfy the selection criteria that we gave earlier. Table S1 showed detailed information (beta, SE, F statistics) of the SNPs selected for vitamins.

After previous adjustment of possible confounders, in the sensitivity test, no group in MR Test showed pleiotropy (Table S4). In the heterogeneity analysis, MR-presso analysis of each group did not find SNPs with significant heterogeneity. However, in our Cochran’s Q test (Table S4), there were three groups with great heterogeneity. Vitamin D is the exposure and Sepsis is the outcome (Q(Q_pval) = 12.379(0.015)). Vitamin D is the exposure and Sepsis (under 75) is the outcome (Q(Q_pval) = 10.573(0.032)). Vitamin C is the exposure and Sepsis (28 day death) is the outcome (Q(Q_pval) = 17.186(0.046)). For these three groups we apply IVW-RE method to Mendelian Randomization Analysis. The vitamin B6 exposure group with only one SNP had taken the Wald ratio method to conduct MR. All the other groups were analyzed by IVW-FE method.

In Mendelian Randomization Analysis studying the association between vitamins and sepsis risk, the effect of vitamins on sepsis was not statistically significant regardless of different kinds of vitamins and the severity of sepsis outcome (P-value > 0. 05, OR (95% confidence intervals) crossed the null line).

The results showed that the concentration changes of vitamin B6, B12, A, D, C, K and folate had no significant effect on the improvement of sepsis of different severity, The ORs (odds ratio) are 1.164 (95% CI:0.895–1.514; folate),0.987 (95% CI: 0.969–1.005; vitamin B6), 0.975 (95% CI: 0.914–1.041; vitamin B12), and 0.993 (95% CI: 0.797–1.238; vitamin A) 0.861(95% CI:0.522–1.42;D); 0.955( 95% CI:0.86–1.059; vitamin K); 1.049(95% CI: 0.911–1.208; vitamin C) respectively; Similar results were seen in subgroups for different severity sepsis. Details in Fig. 2 and Table S4.

Fig. 2
figure 2

Forest plot illustrates causal effects of vitamins on sepsis outcomes. IVW-RE, inverse-variance weighted multiplicative random effects; IVW-FE, inverse-variance weighted multiplicative fixed-effects; OR (95%CI), odds ratio (95% confidence interval); SepsisCC, Sepsis (critical care); SepsisU75, Sepsis (under 75); Sepsis28, Sepsis (28- day death); Sepsis28CC, Sepsis (28 day death in critical care)

Full size image

In another set of mendelian randomization analysis, we investigated whether sepsis of different severity will cause changes in vitamin C concentration. The exposures are different severity of sepsis. We selected ten SNPs for Sepsis, four SNPs for Sepsis (critical care), five SNPs for Sepsis (under 75), fourteen SNPs for Sepsis (28 day death), seven SNPs for Sepsis (28 day death in critical care) at beginning (Table S2). And then several SNPs that were strongly associated with confounders were excluded. For example, rs114920411 is significantly associated with rheumatoid arthritis (P-value = 3. 70E-30) and was excluded. All the SNPs related to confounders were listed in Table S3. And the outcome is plasma vitamin C levels [14]. Our result showed that the ORs (odds ratio) are 1.018 (95% CI: 0.949–1.092; Sepsis), 1.013 (95% CI: 0.981–1.047; SepsisCC), 1.062 (95% CI: 0.944–1.196; SepsisU75), and 1.015 (95% CI: 0.994–1.037; Sepsis28) 0.999 (95% CI: 0.985–1.015;Sepsis28CC) respectively. Sepsis of different severity had no significant association with changes of vitamin C concentration (Fig. 3, Table S5).

Fig. 3
figure 3

Forest plot illustrates causal effects of sepsis on plasma vitamin C concentration outcomes. IVW-RE, inverse-variance weighted multiplicative random effects; IVW-FE, inverse-variance weighted multiplicative fixed-effects; OR (95%CI), odds ratio (95% confidence interval); SepsisCC, Sepsis (critical care); SepsisU75, Sepsis (under 75); Sepsis28, Sepsis (28 day death); Sepsis28CC, Sepsis (28 day death in critical care)

Full size image

Discussion

In this Mendelian Randomization Study, we explored causal relationship of genetically vitamins and sepsis risk and whether sepsis has an effect on changes in vitamin C concentration in the body. Our findings suggest that vitamins were not associated with sepsis risk or improvement or deterioration of sepsis of any severity. Sepsis had no influence of vitamin C concentration. Compared to previous studies, our Mendelian randomization study is the first to use instrumental variables to represent different severity of sepsis and the first to look at the causality between vitamins and sepsis risk genetically. There have been many studies on the effects of vitamins on sepsis, but whether vitamins have a beneficial effect on sepsis is still controversial and remains to be discussed.

Over the last few years, many randomized controlled trials have been conducted to examine whether vitamin C and vitamin D have direct therapeutic effects on sepsis. Many studies have produced contradictory results, however. Sepsis patients who received Intravenous vitamin C injection for more than five days were significantly less likely to require hospitalization and to die within 90 days [22]. Our study and others in the past suggest that vitamins have no effect on sepsis [23]. During 30 days in patients with sepsis, vitamin C did not increase ventilator-free days or vasopressor-free days by a significant amount [24]. Infusion of vitamin C for 96 h also fail to enhance scores for organ dysfunction and reduce damage to the vascular system and inflammatory markers [25]. We provide genetic evidence that vitamin C does not affect sepsis. As for vitamin D, there is some evidence that suggests insufficient vitamin D can lead to a worsening of sepsis. There was an association between inadequate vitamin D and higher risk of severe sepsis in patients admitted with a possible infection to the emergency department [26]. A high-dose vitamin D supplement reduced 28-day mortality in patients with vitamin D deficiency who were critically ill [27]. However, in another study, the similar supplement given to patients could not decrease hospital stay, in-hospital mortality, six-month mortality [28] and showed no advantage over controls in 90-day mortality and other related outcomes [29] in vitamin D-deficient patients in critical condition. In a previous mendelian randomized study, vitamin D was also found to have no therapeutic value for sepsis [30]. Our MR Study replaces the sources of vitamin D exposure and sepsis outcome, but also supports this idea. Previous randomized controlled trials have produced many different results, possibly due to confounders and different time of vitamin administration. To solve this problem, we included cases of sepsis, cases of sepsis in critical care and cases of death (28-day, 75 day). By covering patients with different stages of sepsis, we can conclude that vitamins are not beneficial for different sepsis conditions.

Clinical indicators often indicate a decrease in vitamin C concentration in patients with sepsis [31]. But in our study, we discovered that the serum vitamin C level is not affected by sepsis exposure. We first extracted SNPs that were strongly associated with five different levels of sepsis of varying severity. Then, MR analysis was used to investigate whether sepsis is related to plasma vitamin C levels. Our result may not conflict with past studies. The reduction of ascorbic acid in sepsis patients may be caused by pleiotropic effects in biologic pathways associate with sepsis [32] and there was no direct link between sepsis and plasma vitamin C levels. For instance, vitamin C can scavenge reactive oxygen species (ROS) [33], septic shock patients have significantly depleted vitamin C levels likely due to increased metabolism resulting from the enhanced inflammatory response observed in septic shock. [31]. For vitamin D, clinical research results indicate that lower levels of vitamin D are associated with a higher likelihood of infection and greater disiease severty [34, 35]. Serum vitamin D deficiency may facilitate infections from Staphylococcus aureus and Clostridium difficile, leading to prolonged hospital stays and increased associated costs [36]. Vitamin D levels may be correlated with lower systemic inflammatory cytokines [26]. Some clinical study results suggest a correlation between vitamin D levels and APACHE II and SOFA scores. Vitamin D has pleiotropic regulatory effects, influencing immune function, endothelial cells, mucous membranes, as well as the metabolism of blood glucose and calcium. Vitamin D deficiency results in immune and metabolic dysfunction, contributing to adverse outcomes [37]. However, our study results show that the severity of sepsis is not causally related to vitamin D levels, and there is no genetic association for the susceptibility to sepsis based on vitamin D levels. We believe that, similar to vitamin C, there is no direct causal relationship between vitamin D levels and sepsis severity, this may also explain the current contradictions in clinical research findings.

Vitamin A, K and B vitamins tend to have no direct association with sepsis. Vitamin A is an antioxidant with anti-infection and anti-inflammatory effects and is associated with many inflammatory markers [38]. Vitamin A deficiency in sepsis patients may be triggered by increased metabolic demands and an increase in vitamin A and retinol-binding protein (RBP) excretion in the urine during severe infection [39]. A randomized controlled trial indicated that for septic adult patients, ICU days, ventilator hours, pressor agent usage, or mortality rate in 28 days were not significantly reduced by vitamin A treatment [40]. It is consistent with our study that shows vitamin A has no benefit in curing sepsis. For B vitamins, deficiencies in vitamin B12 and folic acid will adversely affect homocysteine metabolism and lead to hyperhomocysteinemia, which can worsen sepsis. When patients took standardized enteral nutrition and adequate B vitamins, a difference still existed between survivors and nonsurvivors regarding homocysteine concentration [41]. This suggests that vitamin B12 and folic acid may not be associated with hyperhomocysteinemia and worsening sepsis during this process. Another study also found no difference in vitamin B12 and folate concentrations between sepsis patients and healthy controls [42]. This is consistent with our finding that those two vitamins are not related with sepsis. Vitamin B6 is constantly being pointed out to have antioxidant and anti-inflammatory effects [43] in protecting peripheral organs. Vitamin B6 has been suggested to reduce oxidative stress in sepsis [44]. Nevertheless, our study points out that vitamin B6 has no therapeutic value for sepsis, and there is no valid correlation between the two. We did not find any randomized controlled trials directly investigating whether vitamin K can treat sepsis, and only a few literatures have reported the possible correlation between the two. Sepsis is often accompanied by coagulopathy [45]. Proteins Gas6 and protein S, which are vitamin K dependent, are known to activate TAM receptors, which have anti-inflammatory and coagulation properties [46]. However, these potential associations do not reveal whether vitamin K has a therapeutic effect on sepsis, and our study does not suggest a strong association.

We further investigated the role of vitamins in the current clinical practices and guidelines for sepsis. Despite the Surviving Sepsis Campaign (SSC) guidelines weakly recommending against intravenous vitamin C for adult patients with sepsis or septic shock (low-quality evidence) [47], we acknowledge the widespread interest in the use of vitamins in sepsis management. Observational studies suggest that early intravenous administration of vitamin C, when combined with corticosteroids and thiamine, is effective in preventing the gradual deterioration of organ function, including acute kidney injury, and reducing mortality in patients with severe sepsis and septic shock. While as emphasized by subsequent randomized controlled trials (RCTs) and meta-analyses [8, 48], our study results did not directly support a correlation between various vitamins and the risk or severity of sepsis. However, it does not negate the role of vitamins in sepsis, prompting us to pay attention to the indirect pathophysiological changes caused by vitamin levels. Future research needs to comprehensively consider the role of vitamins in sepsis. This should be accomplished through additional large-scale, RCTs to rigorously validate their effects, rather than being incorporated into clinical practice based solely on biological plausibility, low-quality studies, and presumed safety [49].

Our research has some advantages. Using mendelian randomization, we investigated the role of various vitamins in sepsis from a genetic standpoint for the first time. We simultaneously selected five kinds of sepsis of different severity from UK Biobank for research, which made our results more robust. The people studied were all European, reducing the bias caused by demographic stratification. Our results also do not contradict MR’s hypotheses. Some limitations exist in our study. MR studies have inherent limitations, including weak instrumental variables pleiotropy, low statistical power, canalization, population stratification [50]. Firstly, weak instrumental variables could introduce uncertainty in causal inferences, challenging the reliability of the study conclusions. Pleiotropy might introduce unknown confounding factors, making the results more complex and challenging to interpret. Low statistical power could result in the study’s inability to detect true effects, affecting the accuracy of the conclusions. Additionally, canalization and population stratification could introduce biases in the results, and it’s essential to carefully consider the impact of these factors when interpreting the study conclusions. We have tried to address these limitations in our study. Folate, vitamin A, B6, K, have only a few instrumental variables, although no associated bias was detected. Though sepsis of different severity was selected for our study, sepsis is a disease with remarkably heterogeneous condition [51]. Therefore, the selected patients with sepsis still need to further refined according to different Status of illness. Because GWAS data are only available from European populations, our results may not be applicable to all populations. Some isoforms of vitamins were not involved and need to be considered in subsequent studies.

Conclusions

In conclusion, from the perspective of genetic association, our MR study did not find that vitamins (vitamin B6, B12, A, D, C, K and folate) could reduce the risk of sepsis. Sepsis also had no effect on plasma vitamin C levels in the body. More relevant randomized controlled trials need to be conducted to confirm the results.

Data Availability

The UK Biobank data are accessible under application at https://www.ukbiobank.ac.uk/ (accessed date: 12 January 2022), and other all data described in our study are provided within this article.

References

  1. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al. The Third International Consensus definitions for Sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369(9):840–51.

    Article  CAS  PubMed  Google Scholar 

  3. Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Colombara DV, Ikuta KS, Kissoon N, Finfer S, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the global burden of Disease Study. Lancet. 2020;395(10219):200–11.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Bernhard M, Lichtenstern C, Eckmann C, Weigand MA. The early antibiotic therapy in septic patients–milestone or sticking point? Crit Care. 2014;18(6):671.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Gotts JE, Matthay MA. Sepsis: pathophysiology and clinical management. BMJ. 2016;353:i1585.

    Article  PubMed  Google Scholar 

  6. Kuhn SO, Meissner K, Mayes LM, Bartels K. Vitamin C in sepsis. Curr Opin Anaesthesiol. 2018;31(1):55–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Amrein K, Oudemans-van Straaten HM, Berger MM. Vitamin therapy in critically ill patients: focus on thiamine, vitamin C, and vitamin D. Intensive Care Med. 2018;44(11):1940–4.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Lamontagne F, Masse MH, Menard J, Sprague S, Pinto R, Heyland DK, Cook DJ, Battista MC, Day AG, Guyatt GH, et al. Intravenous vitamin C in adults with Sepsis in the Intensive Care Unit. N Engl J Med. 2022;386(25):2387–98.

    Article  CAS  Google Scholar 

  9. Charoenngam N, Holick MF. Immunologic Effects of Vitamin D on Human Health and Disease. Nutrients 2020, 12(7).

  10. Zhang X, Yang K, Chen L, Liao X, Deng L, Chen S, Ji Y. Vitamin A deficiency in critically ill children with sepsis. Crit Care. 2019;23(1):267.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, VanderWeele TJ, Higgins JPT, Timpson NJ, Dimou N, et al. Strengthening the reporting of Observational studies in Epidemiology using mendelian randomization: the STROBE-MR Statement. JAMA. 2021;326(16):1614–21.

    Article  PubMed  Google Scholar 

  12. Yuan S, Mason AM, Carter P, Burgess S, Larsson SC. Homocysteine, B vitamins, and Cardiovascular Disease: a mendelian randomization study. BMC Med. 2021;19(1):97.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Mondul AM, Yu K, Wheeler W, Zhang H, Weinstein SJ, Major JM, Cornelis MC, Mannisto S, Hazra A, Hsing AW, et al. Genome-wide association study of circulating retinol levels. Hum Mol Genet. 2011;20(23):4724–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Zheng JS, Luan J, Sofianopoulou E, Imamura F, Stewart ID, Day FR, Pietzner M, Wheeler E, Lotta LA, Gundersen TE, et al. Plasma Vitamin C and type 2 Diabetes: Genome-Wide Association Study and Mendelian Randomization Analysis in European populations. Diabetes Care. 2021;44(1):98–106.

    Article  CAS  PubMed  Google Scholar 

  15. Jiang X, O’Reilly PF, Aschard H, Hsu YH, Richards JB, Dupuis J, Ingelsson E, Karasik D, Pilz S, Berry D, et al. Genome-wide association study in 79,366 european-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels. Nat Commun. 2018;9(1):260.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Dashti HS, Shea MK, Smith CE, Tanaka T, Hruby A, Richardson K, Wang TJ, Nalls MA, Guo X, Liu Y, et al. Meta-analysis of genome-wide association studies for circulating phylloquinone concentrations. Am J Clin Nutr. 2014;100(6):1462–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, Laurin C, Burgess S, Bowden J, Langdon R et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife 2018, 7.

  18. Kamat MA, Blackshaw JA, Young R, Surendran P, Burgess S, Danesh J, Butterworth AS, Staley JR. PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations. Bioinformatics. 2019;35(22):4851–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Chen L, Yang H, Li H, He C, Yang L, Lv G. Insights into modifiable risk factors of cholelithiasis: a mendelian randomization study. Hepatology. 2022;75(4):785–96.

    Article  CAS  PubMed  Google Scholar 

  20. Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and Diseases. Nat Genet. 2018;50(5):693–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Greco MF, Minelli C, Sheehan NA, Thompson JR. Detecting pleiotropy in mendelian randomisation studies with summary data and a continuous outcome. Stat Med. 2015;34(21):2926–40.

    Article  Google Scholar 

  22. Jung SY, Lee MT, Baek MS, Kim WY. Vitamin C for >/= 5 days is associated with decreased hospital mortality in sepsis subgroups: a nationwide cohort study. Crit Care. 2022;26(1):3.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Rosengrave P, Spencer E, Williman J, Mehrtens J, Morgan S, Doyle T, Van Der Heyden K, Morris A, Shaw G, Carr AC. Intravenous vitamin C administration to patients with septic shock: a pilot randomised controlled trial. Crit Care. 2022;26(1):26.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Sevransky JE, Rothman RE, Hager DN, Bernard GR, Brown SM, Buchman TG, Busse LW, Coopersmith CM, DeWilde C, Ely EW, et al. Effect of vitamin C, thiamine, and hydrocortisone on ventilator- and Vasopressor-Free days in patients with Sepsis: the VICTAS Randomized Clinical Trial. JAMA. 2021;325(8):742–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Fowler AA 3rd, Truwit JD, Hite RD, Morris PE, DeWilde C, Priday A, Fisher B, Thacker LR 2nd, Natarajan R, Brophy DF, et al. Effect of Vitamin C Infusion on Organ failure and biomarkers of inflammation and vascular Injury in patients with Sepsis and severe Acute Respiratory Failure: the CITRIS-ALI randomized clinical trial. JAMA. 2019;322(13):1261–70.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Ginde AA, Camargo CA Jr., Shapiro NI. Vitamin D insufficiency and sepsis severity in emergency department patients with suspected Infection. Acad Emerg Med. 2011;18(5):551–4.

    Article  PubMed  Google Scholar 

  27. Martucci G, McNally D, Parekh D, Zajic P, Tuzzolino F, Arcadipane A, Christopher KB, Dobnig H, Amrein K. Trying to identify who may benefit most from future vitamin D intervention trials: a post hoc analysis from the VITDAL-ICU study excluding the early deaths. Crit Care. 2019;23(1):200.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Amrein K, Schnedl C, Holl A, Riedl R, Christopher KB, Pachler C, Urbanic Purkart T, Waltensdorfer A, Munch A, Warnkross H, et al. Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial. JAMA. 2014;312(15):1520–30.

    Article  PubMed  Google Scholar 

  29. National Heart L, Blood Institute PCTN, Ginde AA, Brower RG, Caterino JM, Finck L, Banner-Goodspeed VM, Grissom CK, Hayden D, Hough CL, et al. Early high-dose vitamin D(3) for critically Ill, vitamin D-Deficient patients. N Engl J Med. 2019;381(26):2529–40.

    Article  Google Scholar 

  30. Çolak Y, Nordestgaard BG, Afzal S. Low vitamin D and risk of bacterial pneumonias: mendelian randomisation studies in two population-based cohorts. Thorax. 2021;76(5):468–78.

    Article  PubMed  Google Scholar 

  31. Carr AC, Rosengrave PC, Bayer S, Chambers S, Mehrtens J, Shaw GM. Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes. Crit Care. 2017;21(1):300.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Wilson JX, Wu F. Vitamin C in sepsis. Subcell Biochem. 2012;56:67–83.

    Article  CAS  Google Scholar 

  33. Carr AC, Shaw GM, Fowler AA, Natarajan R. Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock? Crit Care. 2015;19:418.

    Article  PubMed Central  Google Scholar 

  34. Su LX, Jiang ZX, Cao LC, Xiao K, Song JP, Li H, Zhang X, Yan P, Feng D, Liu CT, et al. Significance of low serum vitamin D for Infection risk, Disease severity and mortality in critically ill patients. Chin Med J (Engl). 2013;126(14):2725–30.

    CAS  PubMed  Google Scholar 

  35. Vanichkulbodee A, Romposra M, Inboriboon PC, Trongtrakul K. Effects of vitamin D insufficiency on sepsis severity and risk of hospitalisation in emergency department patients: a cross-sectional study. BMJ Open. 2023;13(1):e064985.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Youssef D, Bailey B, El Abbassi A, Copeland R, Adebonojo L, Manning T, Peiris AN. Healthcare costs of Staphylococcus aureus and Clostridium difficile Infections in veterans: role of vitamin D deficiency. Epidemiol Infect. 2010;138(9):1322–7.

    Article  CAS  PubMed  Google Scholar 

  37. Baeke F, Gysemans C, Korf H, Mathieu C. Vitamin D insufficiency: implications for the immune system. Pediatr Nephrol. 2010;25(9):1597–606.

    Article  PubMed  Google Scholar 

  38. Gholizadeh M, Basafa Roodi P, Abaj F, Shab-Bidar S, Saedisomeolia A, Asbaghi O, Lak M. Influence of vitamin A supplementation on inflammatory biomarkers in adults: a systematic review and meta-analysis of randomized clinical trials. Sci Rep. 2022;12(1):21384.

    Article  CAS  PubMed Central  Google Scholar 

  39. Stephensen CB, Alvarez JO, Kohatsu J, Hardmeier R, Kennedy JI Jr., Gammon RB Jr. Vitamin A is excreted in the urine during acute Infection. Am J Clin Nutr. 1994;60(3):388–92.

    Article  CAS  PubMed  Google Scholar 

  40. Cherukuri L, Gewirtz G, Osea K, Tayek JA. Vitamin A treatment for severe sepsis in humans; a prospective randomized double blind placebo-controlled clinical trial. Clin Nutr ESPEN. 2019;29:49–51.

    Article  PubMed  Google Scholar 

  41. Ploder M, Kurz K, Spittler A, Neurauter G, Roth E, Fuchs D. Early increase of plasma homocysteine in sepsis patients with poor outcome. Mol Med. 2010;16(11–12):498–504.

    Article  CAS  PubMed  Google Scholar 

  42. Erdem SS, Yerlikaya FH, Cicekler H, Gul M. Association between ischemia-modified albumin, homocysteine, vitamin B(12) and folic acid in patients with severe sepsis. Clin Chem Lab Med. 2012;50(8):1417–21.

    Article  CAS  PubMed  Google Scholar 

  43. Zhang P, Tsuchiya K, Kinoshita T, Kushiyama H, Suidasari S, Hatakeyama M, Imura H, Kato N, Suda T. Vitamin B6 prevents IL-1beta protein production by inhibiting NLRP3 inflammasome activation. J Biol Chem. 2016;291(47):24517–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Giustina AD, Danielski LG, Novochadlo MM, Goldim MPS, Joaquim L, Metzker KLL, Carli RJ, Denicol T, Cidreira T, Vieira T, et al. Vitamin B6 reduces oxidative stress in lungs and liver in experimental sepsis. An Acad Bras Cienc. 2019;91(4):e20190434.

    Article  CAS  PubMed  Google Scholar 

  45. Kinasewitz GT, Yan SB, Basson B, Comp P, Russell JA, Cariou A, Um SL, Utterback B, Laterre PF, Dhainaut JF, et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]. Crit Care. 2004;8(2):R82–90.

    Article  PubMed  PubMed Central  Google Scholar 

  46. van der Meer JH, van der Poll T, van ‘t Veer C. TAM receptors, Gas6, and protein S: roles in inflammation and hemostasis. Blood. 2014;123(16):2460–9.

    Article  PubMed  Google Scholar 

  47. Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, McIntyre L, Ostermann M, Prescott HC, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181–247.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Fujii T, Salanti G, Belletti A, Bellomo R, Carr A, Furukawa TA, Luethi N, Luo Y, Putzu A, Sartini C, et al. Effect of adjunctive vitamin C, glucocorticoids, and vitamin B1 on longer-term mortality in adults with sepsis or septic shock: a systematic review and a component network meta-analysis. Intensive Care Med. 2022;48(1):16–24.

    Article  CAS  PubMed  Google Scholar 

  49. Young PJ, Lamontagne F, Fujii T. Vitamin C in sepsis. Intensive Care Med. 2022;48(11):1621–4.

    Article  CAS  PubMed  Google Scholar 

  50. Wang R. Mendelian randomization study updates the effect of 25-hydroxyvitamin D levels on the risk of multiple sclerosis. J Transl Med. 2022;20(1):3.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Leaf DE, Raed A, Donnino MW, Ginde AA, Waikar SS. Randomized controlled trial of calcitriol in severe sepsis. Am J Respir Crit Care Med. 2014;190(5):533–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

None.

Funding

This work was supported by a grant from Research Incubation Project of the First Affiliated Hospital of Wenzhou Medical University (Grant NO. FHY2019048, WZ); Foundation of Wenzhou City Science & Technology Bureau (Y20210713); Wenzhou High-level Innovation Team for Critical Care and Intelligent Treatment (Grant No. 88923001); Zhejiang Provincial Outstanding Talent Project of Ten Thousand Talents Program (2020R51005).

Author information

Authors and Affiliations

  1. School of The First Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, 325000, China

    Chen Lou

  2. Department of Emergency, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, China

    Zhizhen Meng

  3. Department of Anesthesiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China

    Yiyi Shi

  4. Department of Critical Care Medicine, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310016, China

    Rui Zheng

  5. Department of Intensive Care Unit, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China

    Jingye Pan & Songzan Qian

  6. Wenzhou Key Laboratory of Critical Care and Artificial Intelligence, Wenzhou, China

    Jingye Pan

  7. Key Laboratory of Intelligent Treatment and Life Support for Critical Diseases of Zhejiang Provincial, Wenzhou, Zhejiang, 325000, People’s Republic of China

    Jingye Pan

  8. Zhejiang Engineering Research Center for Hospital Emergency and Process Digitization, Wenzhou, Zhejiang, 325000, China

    Jingye Pan

Authors
  1. Chen Lou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhizhen Meng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yiyi Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rui Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jingye Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Songzan Qian
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

SZ. Q and JY. P designed the study; C.L; YY. S; ZZ.M and R.Z and participated in data collection and analysis. C.L drafted the manuscript.

Corresponding authors

Correspondence to Jingye Pan or Songzan Qian.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lou, C., Meng, Z., Shi, Y. et al. Causal effects of genetically vitamins and sepsis risk: a two-sample Mendelian randomization study. BMC Infect Dis 23, 766 (2023). https://doi.org/10.1186/s12879-023-08778-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12879-023-08778-9

Keywords

BMC Infectious Diseases

ISSN: 1471-2334

Contact us